Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neogen Corp. | 1 | 1 | 0 | 0 | €11.10 | €20.08 | 80.935% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.90 | €7.00 | 1.449% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.89 | €6.53 | 632.586% |
| QuidelOrtho Corp. | 6 | 2 | 0 | 0 | €37.20 | €75.48 | 102.914% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.66 | €3.00 | 355.373% |
| D.Western Therapeutics Institute Inc | 1 | 1 | 0 | 0 | €0.56 | €1.70 | 203.571% |
| Fibrogen Inc. | 1 | 4 | 0 | 0 | €1.05 | €0.000 | -100.000% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.65 | - | - |
| CytoTools AG | 0 | 1 | 0 | 0 | €0.43 | - | - |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.09 | €3.65 | 236.206% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €28.04 | €38.00 | 35.528% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.26 | €7.00 | 209.735% |
| Formycon AG | 3 | 1 | 0 | 0 | €44.20 | €100.00 | 126.244% |
| Elanco Animal Health Inc. | 6 | 3 | 0 | 0 | €12.65 | €15.50 | 22.600% |
| NanoCarrier Co Ltd | 0 | 1 | 0 | 0 | €0.78 | - | - |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.80 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.11 | €3.00 | 42.518% |
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €9.10 | - | - |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.64 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.86 | €8.82 | 927.219% |
| Carl Zeiss Meditec AG | 2 | 1 | 0 | 0 | €99.95 | €101.00 | 1.051% |